Skip to content
Home/Companies/Biotech/GQ Bio Therapeutics

GQ Bio Therapeutics

Biotech·Germany·Exited 2025·Held 13yr
Entry
2012
Hold
13yr
Exit
2025

Who owns GQ Bio Therapeutics?

GQ Bio Therapeutics is a German Biotech company, now owned by Pacira BioSciences, which acquired it in 2025 from IFB Innovationsstarter.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
IFB Innovationsstarter
Investor
IFB Innovationsstarter
Innovationsstarter Fonds Hamburg I · 2012 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Pacira BioSciences
Exit Year
2025

More from Innovationsstarter Fonds Hamburg I

Other portfolio companies in the same fund.

bentekk
Exited 2017
IndustrialsGermany· 2016
to Draeger Safety
Protembis
Protembis
Active
MedTechGermany· 2015
i3 Membrane
i3 Membrane
Active
Deep TechGermany· 2014
CustomCells
CustomCells
Exited 2025
ClimateTechGermany· 2013
to Family office consortium led by ABACON and SALVIA

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns GQ Bio Therapeutics?

GQ Bio Therapeutics is now owned by Pacira BioSciences, which acquired it in 2025 from IFB Innovationsstarter.

When did Pacira BioSciences acquire GQ Bio Therapeutics?

Pacira BioSciences acquired GQ Bio Therapeutics in 2025, buying from IFB Innovationsstarter.

Who did GQ Bio Therapeutics sell to?

IFB Innovationsstarter sold GQ Bio Therapeutics to Pacira BioSciences in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue